BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17111334)

  • 1. Delays in diagnosis and therapy of gastric cancer and esophageal adenocarcinoma.
    Witzig R; Schönberger B; Fink U; Busch R; Gundel H; Sendler A; Peschel C; Siewert JR; Lordick F
    Endoscopy; 2006 Nov; 38(11):1122-6. PubMed ID: 17111334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of metachronous gastric cancers after surgical treatment for esophageal squamous cell carcinoma.
    Kim HJ; Lee JH; Moon TG; Lee JS; Kim YH; Chang DK; Son HJ; Rhee PL; Kim JJ; Rhee JC; Shim YM
    Hepatogastroenterology; 2008; 55(82-83):457-62. PubMed ID: 18613387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirical use of antisecretory drug therapy delays diagnosis of upper gastrointestinal adenocarcinoma but does not effect outcome.
    Panter SJ; O'Flanagan H; Bramble MG; Hungin AP
    Aliment Pharmacol Ther; 2004 May; 19(9):981-8. PubMed ID: 15113364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric adenocarcinoma missed at endoscopy.
    Amin A; Gilmour H; Graham L; Paterson-Brown S; Terrace J; Crofts TJ
    J R Coll Surg Edinb; 2002 Oct; 47(5):681-4. PubMed ID: 12463707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma of the stomach in patients age 35 years and younger: no impact of early diagnosis on survival outcome.
    Windham TC; Termuhlen PM; Ajani JA; Mansfield PF
    J Surg Oncol; 2002 Nov; 81(3):118-24; discussion 124-5. PubMed ID: 12407722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delay in diagnosis of gastric cancer: a prospective study evaluating doctors'- and patients' delay and its influence on five year survival.
    Zilling TL; Walther BS; Ahren B
    Anticancer Res; 1990; 10(2A):411-6. PubMed ID: 2346315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management delays for early gastric cancer in a country without mass screening.
    Look M; Tan YY; Vijayan A; Teh CH; Low CH
    Hepatogastroenterology; 2003; 50(51):873-6. PubMed ID: 12828108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients.
    Dumot JA; Vargo JJ; Falk GW; Frey L; Lopez R; Rice TW
    Gastrointest Endosc; 2009 Oct; 70(4):635-44. PubMed ID: 19559428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary experience comparing routine cytology results with the composite results of digital image analysis and fluorescence in situ hybridization in patients undergoing EUS-guided FNA.
    Levy MJ; Clain JE; Clayton A; Halling KC; Kipp BR; Rajan E; Roberts LR; Root RM; Sebo TJ; Topazian MD; Wang KK; Wiersema MJ; Gores GJ
    Gastrointest Endosc; 2007 Sep; 66(3):483-90. PubMed ID: 17725938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the pattern of presentation and treatment of proximal and distal gastric cancer: results of the 2001 gastric patient care evaluation.
    Wilkinson NW; Howe J; Gay G; Patel-Parekh L; Scott-Conner C; Donohue J
    Ann Surg Oncol; 2008 Jun; 15(6):1644-50. PubMed ID: 18392661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution.
    Ruol A; Castoro C; Portale G; Cavallin F; Sileni VC; Cagol M; Alfieri R; Corti L; Boso C; Zaninotto G; Peracchia A; Ancona E
    Arch Surg; 2009 Mar; 144(3):247-54; discussion 254. PubMed ID: 19289664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base.
    Al-Refaie WB; Tseng JF; Gay G; Patel-Parekh L; Mansfield PF; Pisters PW; Yao JC; Feig BW
    Cancer; 2008 Aug; 113(3):461-9. PubMed ID: 18553367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnosis and management of esophageal and gastric cancer.
    Lang GD; Konda VJ
    Minerva Gastroenterol Dietol; 2013 Dec; 59(4):357-76. PubMed ID: 24212354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends.
    Cooper GS; Kou TD; Chak A
    Am J Gastroenterol; 2009 Jun; 104(6):1356-62. PubMed ID: 19491849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophageal cancer in Stockholm county 1978-1995.
    Stockeld D; Backman L; Fagerberg J; Granström L
    Acta Oncol; 2007; 46(8):1075-84. PubMed ID: 17851831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of endoscopical administration of OK-432 in 4 patients with advanced esophageal or gastric cancer].
    Satomi T; Inoue S; Fujita T; Ogawa S; Honda H; Hayashi M
    Gan No Rinsho; 1989 Mar; 35(4):512-5. PubMed ID: 2541269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric cancer.
    Berridge FE
    Wis Med J; 1988 Oct; 87(10):11-3. PubMed ID: 3232394
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic delay experienced among gynecological cancer patients: a nationwide survey in Denmark.
    Robinson KM; Ottesen B; Christensen KB; Krasnik A
    Acta Obstet Gynecol Scand; 2009; 88(6):685-92. PubMed ID: 19455442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study.
    Strong VE; Devaud N; Allen PJ; Gonen M; Brennan MF; Coit D
    Ann Surg Oncol; 2009 Jun; 16(6):1507-13. PubMed ID: 19347407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.